Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis

Figure 3

Proportion of patients receiving each type of Parkinson’s disease medication in the 6-month periods before and after the index date; (a) levodopa, catechol-O-methyltransferase inhibitors (COMT-I) and monoamine oxidase B inhibitors (MAOB-I); (b) dopamine agonists; (c) anticholinergic medications and other drugs. DCI, decarboxylase inhibitor.

(a)

(b)

(c)